Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.


Journal

Respirology (Carlton, Vic.)
ISSN: 1440-1843
Titre abrégé: Respirology
Pays: Australia
ID NLM: 9616368

Informations de publication

Date de publication:
04 2019
Historique:
received: 02 07 2018
revised: 13 08 2018
accepted: 23 09 2018
pubmed: 18 10 2018
medline: 24 4 2020
entrez: 18 10 2018
Statut: ppublish

Résumé

Current guidelines for the diagnosis of idiopathic pulmonary fibrosis (IPF) provide specific criteria for diagnosis in the setting of multidisciplinary discussion (MDD). We evaluate the utility and reproducibility of these diagnostic guidelines, using clinical data from the Australian IPF Registry. All patients enrolled in the registry undergo a diagnostic review whereby international IPF guidelines are applied via a registry MDD. We investigated the clinical applicability of these guidelines with regard to: (i) adherence to guidelines, (ii) Natural history of IPF diagnostic categories and (iii) Concordance for diagnostic features. A total of 417 participants (69% male, 70.6 ± 8.0 years) with a clinical diagnosis of IPF underwent MDD. The 23% of participants who did not meet IPF diagnostic criteria displayed identical disease behaviour to those with confirmed IPF. Honeycombing on radiology was associated with a worse prognosis and this translated into poorer prognosis in the 'definite' IPF group. While there was moderate agreement for IPF diagnostic categories, agreement for specific radiological features, other than honeycombing, was poor. In clinical practice, physicians do not always follow IPF diagnostic guidelines. We demonstrate a cohort of IPF patients who do not meet IPF diagnostic guideline criteria, based largely on their radiology and lack of lung biopsy, but who have outcomes identical to those with IPF.

Sections du résumé

BACKGROUND AND OBJECTIVE
Current guidelines for the diagnosis of idiopathic pulmonary fibrosis (IPF) provide specific criteria for diagnosis in the setting of multidisciplinary discussion (MDD). We evaluate the utility and reproducibility of these diagnostic guidelines, using clinical data from the Australian IPF Registry.
METHODS
All patients enrolled in the registry undergo a diagnostic review whereby international IPF guidelines are applied via a registry MDD. We investigated the clinical applicability of these guidelines with regard to: (i) adherence to guidelines, (ii) Natural history of IPF diagnostic categories and (iii) Concordance for diagnostic features.
RESULTS
A total of 417 participants (69% male, 70.6 ± 8.0 years) with a clinical diagnosis of IPF underwent MDD. The 23% of participants who did not meet IPF diagnostic criteria displayed identical disease behaviour to those with confirmed IPF. Honeycombing on radiology was associated with a worse prognosis and this translated into poorer prognosis in the 'definite' IPF group. While there was moderate agreement for IPF diagnostic categories, agreement for specific radiological features, other than honeycombing, was poor.
CONCLUSION
In clinical practice, physicians do not always follow IPF diagnostic guidelines. We demonstrate a cohort of IPF patients who do not meet IPF diagnostic guideline criteria, based largely on their radiology and lack of lung biopsy, but who have outcomes identical to those with IPF.

Identifiants

pubmed: 30328644
doi: 10.1111/resp.13427
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-368

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 Asian Pacific Society of Respirology.

Auteurs

Helen E Jo (HE)

Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.

Ian Glaspole (I)

National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.
Department of Allergy and Respiratory Medicine, The Alfred Hospital, Melbourne, VIC, Australia.
Faculty of Medicine, Monash University, Melbourne, VIC, Australia.

Nicole Goh (N)

Department of Allergy and Respiratory Medicine, The Alfred Hospital, Melbourne, VIC, Australia.
Department of Respiratory Medicine, Austin Hospital, Melbourne, VIC, Australia.
Institute for Breathing and Sleep, Melbourne, VIC, Australia.

Peter M A Hopkins (PMA)

National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.
School of Medicine, University of Queensland, Brisbane, QLD, Australia.

Yuben Moodley (Y)

National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.
Department of Respiratory Medicine, Fiona Stanley Hospital, Perth, WA, Australia.

Paul N Reynolds (PN)

Department of Respiratory Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.
Department of Medicine, University of Adelaide, Adelaide, SA, Australia.

Sally Chapman (S)

Department of Respiratory Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.

Eugene Haydn Walters (EH)

National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.
Department of Medicine, University of Tasmania, Hobart, TAS, Australia.

Christopher Zappala (C)

Department of Thoracic Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Heather Allan (H)

Lung Foundation Australia, Brisbane, QLD, Australia.

Sacha Macansh (S)

Lung Foundation Australia, Brisbane, QLD, Australia.

Christopher Grainge (C)

National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.
Department of Respiratory Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

Gregory J Keir (GJ)

Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, QLD, Australia.

Andrew Hayen (A)

Department of Public Health, University of Technology, Sydney, NSW, Australia.

Douglas Henderson (D)

Department of Anatomical pathology, Flinders Medical Centre, Adelaide, SA, Australia.

Sonja Klebe (S)

Department of Radiology, Royal Melbourne Hospital, Adelaide, SA, Australia.

Stefan B Heinze (SB)

Department of Radiology, Royal Melbourne Hospital, Adelaide, SA, Australia.

Anne Miller (A)

Department of Radiology, Royal North Shore Hospital, Sydney, NSW, Australia.

Hannah C Rouse (HC)

Department of Radiology, St Vincent's Hospital, Melbourne, VIC, Australia.

Edwina Duhig (E)

Department of Anatomical Pathology, Sullivan Nicolaides Pathology, Brisbane, QLD, Australia.

Wendy A Cooper (WA)

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Annabelle M Mahar (AM)

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Samantha Ellis (S)

Department of Radiology, The Alfred Hospital, Melbourne, VIC, Australia.

Samuel R McCormack (SR)

Department of Radiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Bernard Ng (B)

Department of Radiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

David B Godbolt (DB)

Pathology Queensland, The Prince Charles Hospital, Brisbane, QLD, Australia.

Tamera J Corte (TJ)

Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
National Health and Medical Research Council Centre of Research Excellence in Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH